What is vasodilatory shock in critically ill patients with conditions such as sepsis, trauma, or severe burns, and those with a history of cardiovascular, renal, or hepatic dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasodilatory Shock: Definition and Clinical Characteristics

Vasodilatory shock is a life-threatening circulatory failure characterized by pathological peripheral vasodilation leading to severely decreased systemic vascular resistance (SVR), resulting in profound hypotension and tissue hypoperfusion despite normal or elevated cardiac output. 1, 2

Pathophysiology

The fundamental hemodynamic abnormality in vasodilatory shock is uncontrolled vasodilation and vascular hyporesponsiveness to endogenous vasoconstrictors, causing failure of physiologic vasoregulatory mechanisms 2. This creates a state of relative hypovolemia where blood volume is insufficient to fill the pathologically dilated vascular space 1.

Key pathophysiological features include:

  • Decreased systemic vascular resistance as the hallmark finding, distinguishing it from cardiogenic shock where SVR is elevated 3, 1
  • Normal or elevated cardiac output in early stages, contrasting with the reduced cardiac output seen in cardiogenic and hypovolemic shock 3, 4
  • Abnormal distribution of microvascular blood flow resulting in metabolic distress despite potentially adequate cardiac output 1
  • Vasopressin deficiency appears to play a significant role in the pathophysiology 5

Common Etiologies

Vasodilatory shock occurs in multiple critical illness contexts:

  • Septic shock - the most common cause and leading etiology of critical illness-related mortality 3, 5
  • Anaphylaxis 1
  • Neurogenic shock (from spinal cord injury) 6
  • Severe pancreatitis 1
  • Major burns 1
  • Post-cardiotomy shock 7

Hemodynamic Profile

The characteristic hemodynamic pattern that distinguishes vasodilatory shock includes:

  • Low systemic vascular resistance (opposite of cardiogenic shock) 3
  • High or normal cardiac index (>3.3 L/min/m² or normal range) 3, 4
  • Normal or decreased central venous pressure (not elevated as in cardiogenic shock) 4
  • Normal or decreased pulmonary capillary wedge pressure 3
  • Hypotension refractory to fluid administration as the cardinal feature 1

Clinical Presentation

Patients with vasodilatory shock typically present with:

  • Profound hypotension (systolic BP <90 mmHg or MAP <65 mmHg) despite fluid resuscitation 3, 1
  • Warm extremities (in contrast to the cool extremities of cardiogenic shock) 3
  • Tachycardia as a compensatory mechanism 1
  • Altered mental status from cerebral hypoperfusion 1
  • Decreased urine output (<0.5 mL/kg/h) reflecting renal hypoperfusion 1
  • Elevated serum lactate (>2 mmol/L) indicating tissue hypoxia and anaerobic metabolism 3, 1

Important Clinical Distinction

Vasodilatory shock with high cardiac output and low SVR must be distinguished from cardiogenic shock, which presents with low cardiac output, high SVR, and elevated filling pressures 3, 4. This distinction is critical because treatment strategies differ fundamentally - vasodilatory shock requires vasopressors to restore vascular tone, while cardiogenic shock may require afterload reduction 3.

Myocardial Depression Complication

Up to one-third of patients with vasodilatory shock, particularly septic shock, develop myocardial depression with reduced cardiac output despite the primary vasodilatory pathophysiology 3, 1. When this occurs, the hemodynamic profile shifts to low cardiac output with low SVR 3, requiring addition of inotropic support alongside vasopressors 3.

Refractory Vasodilatory Shock

Approximately 7% of critically ill patients develop refractory vasodilatory shock, defined as inadequate hemodynamic response to high doses of vasopressor medications, with short-term mortality exceeding 50% 2. This represents the most severe manifestation requiring aggressive multimodal vasopressor therapy 2, 8.

References

Guideline

Distributive Shock Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Vasopressin in Vasodilatory Shock.

Critical care clinics, 2019

Guideline

Neurogenic Shock Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacologic Agents for the Treatment of Vasodilatory Shock.

Current pharmaceutical design, 2019

Related Questions

What vasopressors are used to treat the 4 types of shock: hypovolemic, cardiogenic, obstructive, and distributive?
What is the best initial fluid for a patient in shock with anxiety, restlessness, confusion, and hypotension (low blood pressure)?
What is the best vasopressor for managing hypotension (low blood pressure) in angioedema?
What are the mechanisms of action, treatment guidelines, contraindications, and monitoring requirements for beta (beta) receptors, alpha (alpha) receptors, ionotropes, and vasopressors in clinical practice?
What are the 4 types of shock, including Hypovolemic (low blood volume) shock, Cardiogenic (heart-related) shock, Distributive (circulatory) shock, and Obstructive (blockage-related) shock?
What is the appropriate management for a patient presenting with a swollen tongue, considering potential causes such as allergies, autoimmune disorders, or trauma, and the risk of airway compromise?
What is the best course of treatment for a patient with Systemic Lupus Erythematosus (SLE) presenting with nuchal rigidity and seizure?
Can rosuvastatin (statin) cause palpitations?
What is the recommended per enteral (by mouth) iron supplementation regimen for a patient with chronic kidney disease (CKD) and iron deficiency anemia?
What is the recommended treatment approach for a pediatric or young adult patient diagnosed with osteosarcoma?
What are the potential causes and management options for a patient with a history of chest pain and gastrointestinal symptoms who may be experiencing referred pain from the Rhomboidus muscle?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.